Member Info for gspanner

Hightower,

I am very interested about your experience with the software… Can you elaborate please?

Thanks in advance.

Well well. not sure what this is all about, games within games no doubt, unless the company is leaky?

Just had a look at the vols of the chart… Looks like something has been up for a while… biggest vols today for some time, nice incremental increase suggesting it’s on some radars….

Ooh, I really like the PDL1 study, could be a game changer that one…. need to correlate CTC expression with response in those with negative (and positive biospises), but that is a relatively straightforward study to do.

So just to put this into context, pharma are spending hundreds of millions (probably billions) developing semi individualised RNA vaccines to increase sensitivity to immunotherapy. currently thought from some data that this may increase response by about 25%…. They are of course excruciatingly expensive.

So this is an assay that suggests some of the 27% of initially negative biopsy samples may have some response… All in a relatively simple off the shelf diagnostic test…

It’s almost like a strategy 🤔😆

Sorry not just marketing but fintech, legal recruitment…. and likely more.

And Recruitment!

Well another partnership where we don’t know what the revenue will be… But there is some reassurance perhaps of the versatility of the software - but just marketing bit also fintech and legal applications.

I Don’t… In suspect there are many more, including those who have bespoke solutions and the software sold via partnerships… But you would have thought if they were now actively marketing the app it might be shown on there.

What we need is the actual amount/some sort of trading guidance Mr Bixby!

No 😆

Well the plot thickens! Will the numbers on the ‘Chrome App page ‘start to rise dramatically?

Yes but we don’t know that the users correspond to the total number of users or revenue do we?

Looking at the numbers if they compound 10%/month is meaningful just depends on margins/cost per user which we still don’t know.

I do understand a cautious approach though… U.K. complainies tend not to be valued in hope after all!

Observing the app over the last 3 weeks since I started monitoring it shows an increase in users, but not entirely linear… 316 16/8, 347 today. Over what time period are you talking about?

Now up to 354 users…

Whilst waiting for any concrete numbers/trading update etc I have seen on this Google Chrome website…

hTTps://chromewebstore.google.com/detail/cykel-ai-task-automation/mcjcpjokomkmeenbokgamhfenijiggje?hl=en-GB

So 16th Aug 2 weeks ago there were 316 users and today 333, so an increase of about 5% in 2 weeks. So I have no idea whether these are all the users of the software or just a proportion. If however they were expanding users by 10%/month and this was compounding that would be pretty reasonable IMO.

Summer may be a less prolific period, so will be interesting to look over the next 2 weeks.

Well big old rollovers before and after the bell. Folk holding onto stock, feels quite tightly held now.

Ok well quick look - Simera’s estimated revenues from ‘growjo’ $22.5m… So doing some business:

hTTps://growjo.com/company/Simera

It also occurred to me if Bixby can give 2mil to charity then he may not need to draw the usual £250k salary that often depletes the cash of start up companies… Given the margin on the software is likely high salaries must be the major expense. Again results may reveal some detail here.

Worth having a read of the ‘x’ feed also…

hTTps://x.com/CykelAI

hTTps://x.com/CykelAI/status/1825574492829036734

All aboard now I hope?

Or slowly, slowly I meant